Latest Asx News

Syntara Limited has initiated dosing in its Phase 1c SATELLITE trial for a novel topical treatment targeting keloid scars, marking a significant step in addressing a $3.5 billion global market. The study, led by Professor Fiona Wood, will evaluate safety and early efficacy over three months.

Imagion Biosystems has received encouraging feedback from the FDA on its MagSense HER2 breast cancer imaging program, clearing the path for a Phase 2 clinical trial and fast-tracking manufacturing.

Nova Minerals has priced a US$11.1 million underwritten public offering on NASDAQ, aiming to boost exploration and development at its Estelle Gold and Critical Minerals Project in Alaska.

Iltani Resources has completed its JORC infill drilling program at the Orient West Silver-Indium Project in Queensland, delivering multiple high-grade assay results that confirm mineralisation continuity and set the stage for an initial JORC Resource estimate by July’s end.

Prescient Therapeutics has extended its Share Purchase Plan closing date to 22 July 2025, aiming to raise up to A$7 million to advance its targeted cancer therapy PTX-100 through Phase 2 clinical trials.

Argent Minerals is fast-tracking diamond drilling and metallurgical testwork at its Kempfield Polymetallic Project to underpin a scoping study aimed at early cash flow and long-term development.

Rapid Critical Metals Limited (ASX, RCM) has unveiled a strategic acquisition of two high-grade silver projects in New South Wales and a critical metals project in British Columbia, supported by a proposed $10 million capital raise.

Verity Resources is set to begin a 3,600m drilling campaign aimed at upgrading and expanding its Monument Gold Project resource in Western Australia. The program targets the Korong deposit with the goal of moving from inferred to indicated resource status.

Janison Education Group has been appointed by the New Zealand Ministry of Education to deliver a new bilingual digital assessment platform for students in Years 3 to 10, marking a strategic expansion into the New Zealand education sector.

Lumos Diagnostics has voluntarily suspended its ASX trading pending a market announcement about strategic agreements, signaling potential shifts in its business trajectory.

Aurum Resources has completed a A$35.6 million strategic placement, bolstering its cash reserves to over A$45 million and enabling accelerated development of its Boundiali and Napié gold projects in Côte d’Ivoire.

RBR Group Limited invites eligible shareholders to participate in a Share Purchase Plan aiming to raise up to $650,000 by offering shares at a highly discounted price of $0.001 each. The capital raised will support a joint venture, debt repayment, and working capital needs.